Gilks CB - Search Results

1

Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization.

Lheureux S, Lai Z, Dougherty BA, Runswick S, Hodgson DR, Timms KM, Lanchbury JS, Kaye S, Gourley C, Bowtell D, Kohn EC, Scott C, Matulonis U, Panzarella T, Karakasis K, Burnier JV, Gilks CB, O'Connor MJ, Robertson JD, Ledermann J, Barrett JC, Ho TW, Oza AM. Lheureux S, et al. Among authors: gilks cb. Clin Cancer Res. 2017 Aug 1;23(15):4086-4094. doi: 10.1158/1078-0432.CCR-16-2615. Epub 2017 Feb 21. Clin Cancer Res. 2017. PMID: 28223274 Clinical Trial.

2

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM. Nielsen TO, et al. Among authors: gilks cb. Clin Cancer Res. 2004 Aug 15;10(16):5367-74. doi: 10.1158/1078-0432.CCR-04-0220. Clin Cancer Res. 2004. PMID: 15328174

3

Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas.

Woo MM, Salamanca CM, Miller M, Symowicz J, Leung PC, Oliveira C, Ehlen TG, Gilks CB, Huntsman D, Auersperg N. Woo MM, et al. Among authors: gilks cb. Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1234-47. doi: 10.1111/j.1525-1438.2007.01171.x. Epub 2008 Jan 23. Int J Gynecol Cancer. 2008. PMID: 18217967

4

Prognostic significance of macrophage infiltration in leiomyosarcomas.

Lee CH, Espinosa I, Vrijaldenhoven S, Subramanian S, Montgomery KD, Zhu S, Marinelli RJ, Peterse JL, Poulin N, Nielsen TO, West RB, Gilks CB, van de Rijn M. Lee CH, et al. Among authors: gilks cb. Clin Cancer Res. 2008 Mar 1;14(5):1423-30. doi: 10.1158/1078-0432.CCR-07-1712. Clin Cancer Res. 2008. PMID: 18316565

5

Critical molecular abnormalities in high-grade serous carcinoma of the ovary.

Köbel M, Huntsman D, Gilks CB. Köbel M, et al. Among authors: gilks cb. Expert Rev Mol Med. 2008 Aug 1;10:e22. doi: 10.1017/S146239940800077X. Expert Rev Mol Med. 2008. PMID: 18671886 Review.

6

MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary.

Lee CH, Subramanian S, Beck AH, Espinosa I, Senz J, Zhu SX, Huntsman D, van de Rijn M, Gilks CB. Lee CH, et al. Among authors: gilks cb. PLoS One. 2009 Oct 2;4(10):e7314. doi: 10.1371/journal.pone.0007314. PLoS One. 2009. PMID: 19798417 Free PMC article.

7

The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.

Köbel M, Reuss A, du Bois A, Kommoss S, Kommoss F, Gao D, Kalloger SE, Huntsman DG, Gilks CB. Köbel M, et al. Among authors: gilks cb. J Pathol. 2010 Oct;222(2):191-8. doi: 10.1002/path.2744. J Pathol. 2010. PMID: 20629008

8

Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation.

Pradhan M, Risberg BA, Tropé CG, van de Rijn M, Gilks CB, Lee CH. Pradhan M, et al. Among authors: gilks cb. BMC Cancer. 2010 Sep 15;10:493. doi: 10.1186/1471-2407-10-493. BMC Cancer. 2010. PMID: 20843305 Free PMC article.

9

Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts.

Kortmann U, McAlpine JN, Xue H, Guan J, Ha G, Tully S, Shafait S, Lau A, Cranston AN, O'Connor MJ, Huntsman DG, Wang Y, Gilks CB. Kortmann U, et al. Among authors: gilks cb. Clin Cancer Res. 2011 Feb 15;17(4):783-91. doi: 10.1158/1078-0432.CCR-10-1382. Epub 2010 Nov 19. Clin Cancer Res. 2011. PMID: 21097693

10

IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.

Anglesio MS, George J, Kulbe H, Friedlander M, Rischin D, Lemech C, Power J, Coward J, Cowin PA, House CM, Chakravarty P, Gorringe KL, Campbell IG; Australian Ovarian Cancer Study Group; Okamoto A, Birrer MJ, Huntsman DG, de Fazio A, Kalloger SE, Balkwill F, Gilks CB, Bowtell DD. Anglesio MS, et al. Among authors: gilks cb. Clin Cancer Res. 2011 Apr 15;17(8):2538-48. doi: 10.1158/1078-0432.CCR-10-3314. Epub 2011 Feb 22. Clin Cancer Res. 2011. PMID: 21343371 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

427 results

Search Page